Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic'. Together they form a unique fingerprint.

Medicine & Life Sciences